Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing January 17, 2024 07:17 AM Eastern Standard Time CLEVELAND–(BUSINESS WIRE)–Cleveland Diagnostics, Inc., a clinical-stage biotechnology company…